In this episode, the team from the Henry Ford Health System to discuss their award winning submission to the ASHP Best Practices.  They will share how the addition of a pharmacist to the multidisciplinary interstitial lung disease (ILD) team, along with the robust collaboration with a specialty pharmacy, improved the quality of patient care in ILD and generated significant revenue for their health system.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.